FindTrial
Sign In

Regulation of skin tumorigenesis by integrin a3β1

Regulation of skin tumorigenesis by integrin a3β1 - Integrin a3β1 in skin carcinogenesis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44700
Enrollment
Unknown
Registered
2013-11-07
Start date
2013-10-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immunohistology Integrin &alfa

Interventions

None listed

Sponsors

Antoni van Leeuwenhoek Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Be 18 years or older. • Histologically confirmed keratoacanthoma, actinic keratosis, Bowens disease or squamous cell carcinoma. • Lesions have to be either in the head and neck region or on the trunk and extremities.

Exclusion criteria

Exclusion criteria: • If receiving any anti-cancer therapies • Prior surgery, radiotherapy or cryotherapy in the affected skin area.

Design outcomes

Primary

MeasureTime frame
none—

Secondary

MeasureTime frame
none—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)